Frequency of somatic TP53 mutations in non-small cell lung cancer in Kazakhstan

被引：0
|
作者：
Zhuraliyeva, A. [1 ]
Wang, J. [2 ]
Khamdiyeva, O. [1 ]
Abdullaev, Z. [2 ]
Pack, S. [2 ]
Biyasheva, Z. [1 ]
机构：
[1] Al Farabi Kazakh Natl Univ, Sci Res Inst Issues Biol & Biotechnol, Alma Ata, Kazakhstan
[2] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
FEBS OPEN BIO | 2019年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-35-114
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [41] Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
    Zhao, Jiayi
    Han, Yiping
    Li, Jiamei
    Chai, Rong
    Bai, Chong
    ONCOLOGY LETTERS, 2019, 17 (03) : 3233 - 3240
  • [42] TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
    Liu, Surui
    Yu, Jin
    Zhang, Hui
    Liu, Jie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer TP53 mutations
    Fukuda, Koji
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Sato, Shigeki
    Kotani, Hiroshi
    Kita, Kenji
    Nishiyama, Akihiro
    Sakaguchi, Hiroyuki
    Ohtsubo, Koshiro
    Yano, Seiji
    CELL REPORTS MEDICINE, 2024, 5 (06)
  • [44] The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer
    Zhang, YuXuan
    Shen, Yuhong
    Wu, Jiayuan
    Zhang, Jun
    Cao, Chenxi
    Mo, Juanfen
    Bao, Yi
    ONCOTARGETS AND THERAPY, 2024, 17 : 755 - 763
  • [45] Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
    Canale, Matteo
    Petracci, Elisabetta
    Cravero, Paola
    Mariotti, Marita
    Minuti, Gabriele
    Metro, Giulio
    Ludovini, Vienna
    Baglivo, Sara
    Puccetti, Maurizio
    Dubini, Alessandra
    Martinelli, Giovanni
    Delmonte, Angelo
    Crino, Lucio
    Ulivi, Paola
    TRANSLATIONAL ONCOLOGY, 2022, 23
  • [46] Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants
    Deben, Christophe
    Van den Bossche, Jolien
    Van Der Steen, Nele
    Lardon, Filip
    Wouters, An
    de Beeck, Ken Op
    Hermans, Christophe
    Jacobs, Julie
    Peeters, Marc
    Van Camp, Guy
    Rolfo, Christian
    Deschoolmeester, Vanessa
    Pauwels, Patrick
    TUMOR BIOLOGY, 2017, 39 (02)
  • [47] Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer
    Tomasini, Pascale
    Mascaux, Celine
    Jao, Kevin
    Labbe, Catherine
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Hwang, David M.
    Leighl, Natasha B.
    Liu, Geoffrey
    Bradbury, Penelope A.
    Pintilie, Melania
    Tsao, Ming-Sound
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2019, 20 (03) : E338 - E345
  • [48] The study of TP53 gene in patients with small cell lung cancer
    Gimalova, G. F.
    Abdullin, Z. S.
    Nizamova, A. R.
    Klimentova, E. A.
    Gilyazova, I. R.
    Sakaeva, D. D.
    Khusnutdinova, E. K.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1903 - 1903
  • [49] Prognostic Value of TP53 Hot Exon Mutation in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    He, Y.
    Guo, R.
    Liu, Y.
    Xu, F.
    Wang, Y.
    Cao, J.
    Wu, Q.
    Han, Z.
    Ye, J.
    Zhang, L.
    Mao, X.
    Zhang, Z.
    Liu, J.
    Zhang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S681 - S682
  • [50] TP53 affects SOX2 copy number alterations and expression in non-small cell lung cancer
    Samulin-Erdem, Johanna
    Skaug, Vidar
    Bakke, Per
    Gulsvik, Amund
    Haugen, Aage
    Zienolddiny, Shanbeh
    CANCER RESEARCH, 2015, 75
12345